Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Additional patent coverage for Maxim anticancer combination

Sep. 6, 1996

AltaRex and Medac finalize Ovarex partnership

Aug. 30, 1996

Imutec/NaPro BioTherapeutics sign research agreement

Aug. 23, 1996

C242-DM1: Promising new approach to colorectal cancer treatment

Aug. 23, 1996

MDX-210 efficacy/safety trial begins in U.K.

Aug. 23, 1996

Progenic's GMK undergoes phase III clinical trials

Aug. 23, 1996

AltaRex awaits Canadian approval to begin Ovarex phase II/III trials

Aug. 23, 1996

European approval sought for new Rebif indications

Aug. 23, 1996

U.S. patent will issue covering GLIOMAB-H

Aug. 16, 1996

BEC2, ImClone Systems' therapeutic vaccine protected under U.S. patent

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...